Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Harvard Business School
Merck
Moodys
McKinsey

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Linifanib

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Linifanib: Sponsors, patents, clinical trial progress

Linifanib is an investigational drug.

There have been 11 clinical trials for Linifanib. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2010.

The most common disease conditions in clinical trials are Carcinoma, Liver Diseases, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are Abbott, AbbVie (prior sponsor, Abbott), and Genentech, Inc.

There are seventy US patents protecting this investigational drug and eight hundred and nine international patents.

Recent Clinical Trials for Linifanib
TitleSponsorPhase
Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the EndometriosisBioGene Pharmaceutical Ltd.Phase 1/Phase 2
A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid TumorsAbbottPhase 1
A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors.AbbottPhase 1

See all Linifanib clinical trials

Clinical Trial Summary for Linifanib

Top disease conditions for Linifanib
Top clinical trial sponsors for Linifanib

See all Linifanib clinical trials

US Patents for Linifanib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Linifanib   Start Trial Antibody drug conjugates Novartis AG (Basel, CH)   Start Trial
Linifanib   Start Trial Organic compositions to treat beta-catenin-related diseases Arrowhead Pharmaceuticals, Inc. (Pasadena, CA)   Start Trial
Linifanib   Start Trial Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders Novartis AG (Basel, CH)   Start Trial
Linifanib   Start Trial N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 Novartis AG (Basel, CH)   Start Trial
Linifanib   Start Trial 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 Novartis AG (Basel, CH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Linifanib

Drugname Country Document Number Estimated Expiration Related US Patent
Linifanib Argentina 102649 2034-11-14   Start Trial
Linifanib Australia 2015347015 2034-11-14   Start Trial
Linifanib Brazil 112017009813 2034-11-14   Start Trial
Linifanib Canada 2967188 2034-11-14   Start Trial
Linifanib Chile 2017001217 2034-11-14   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Dow
Merck
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.